Works matching IS 18696953 AND DT 2022 AND VI 13 AND IP 3
Results: 12
Safety and Effectiveness of Insulin Glargine 300 U/mL in Participants with Type 2 Diabetes Who Fast During Ramadan in The Gulf Region: A Subgroup Analysis of the Real-World ORION Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 569, doi. 10.1007/s13300-022-01225-z
- By:
- Publication type:
- Article
Cystic Fibrosis-Related Diabetes Mellitus and Pregnancy: A Retrospective Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 481, doi. 10.1007/s13300-022-01223-1
- By:
- Publication type:
- Article
The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 489, doi. 10.1007/s13300-022-01221-3
- By:
- Publication type:
- Article
Conversations and Reactions Around Severe Hypoglycemia (CRASH): Japan Results From a Global Survey of People with T1DM or Insulin-Treated T2DM and Caregivers.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 517, doi. 10.1007/s13300-022-01211-5
- By:
- Publication type:
- Article
Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 551, doi. 10.1007/s13300-022-01218-y
- By:
- Publication type:
- Article
Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 535, doi. 10.1007/s13300-022-01216-0
- By:
- Publication type:
- Article
Mortality Rate Associated with Diabetes: Outcomes From a General Practice Level Analysis in England Using the Royal College of General Practitioners (RCGP) Database Indicate Stability Over a 15 Year Period.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 505, doi. 10.1007/s13300-022-01215-1
- By:
- Publication type:
- Article
Effect of Digital Lifestyle Management on Metabolic Control and Quality of Life in Patients with Well-Controlled Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 423, doi. 10.1007/s13300-022-01214-2
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes Before and After Humulin R U-500 Initiation Among US Patients with Type 2 Diabetes Previously Prescribed ≤ 200 Units/day of U-100 Insulin.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 465, doi. 10.1007/s13300-022-01209-z
- By:
- Publication type:
- Article
Liraglutide Improved Cardiometabolic Parameters More in Obese than in Non-obese Patients with Type 2 Diabetes: A Real-World 18-Month Prospective Study.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 453, doi. 10.1007/s13300-022-01217-z
- By:
- Publication type:
- Article
Clinical Characteristics of Peripheral Neuropathy in Kenyan Patients with HIV Infection Compared with Patients with Concurrent HIV Infection and Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 441, doi. 10.1007/s13300-022-01205-3
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 3, p. 389, doi. 10.1007/s13300-021-01198-5
- By:
- Publication type:
- Article